Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CBM588 |
Trade Name | |
Synonyms | CBM 588|C. butyricum CBM 588 probiotic strain|MIYAIRI 588 |
Drug Descriptions |
CBM588 is a strain of Clostridium butyricum used as a probiotic, which induces the release of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), potentially resulting in increased tumor cell death and decreased tumor growth (PMID: 23354042). |
DrugClasses | Microbiome 7 |
CAS Registry Number | 1034072-22-4 |
NCIT ID | C154674 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cabozantinib + CBM588 + Nivolumab | CBM588 Cabozantinib Nivolumab | 0 | 1 |
CBM588 | CBM588 | 0 | 0 |
CBM588 + Ipilimumab + Nivolumab | CBM588 Ipilimumab Nivolumab | 0 | 2 |